These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

894 related items for PubMed ID: 15170633

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [Abstract] [Full Text] [Related]

  • 3. Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load.
    Hofer H, Watkins-Riedel T, Janata O, Penner E, Holzmann H, Steindl-Munda P, Gangl A, Ferenci P.
    Hepatology; 2003 Jan; 37(1):60-4. PubMed ID: 12500189
    [Abstract] [Full Text] [Related]

  • 4. Natural history of acute symptomatic hepatitis type C.
    Wawrzynowicz-Syczewska M, Kubicka J, Lewandowski Z, Boroń-Kaczmarska A, Radkowski M.
    Infection; 2004 Jun; 32(3):138-43. PubMed ID: 15188072
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V, Núñez M, Camino N, Maida I, Barreiro P, Romero M, Martin-Carbonero L, Garcia-Samaniego J, González-Lahoz J.
    Antivir Ther; 2004 Aug; 9(4):505-9. PubMed ID: 15456081
    [Abstract] [Full Text] [Related]

  • 6. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
    Chu CM, Sheen IS, Liaw YF.
    Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
    Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kuzuya T, Honda T, Hayashi K, Nakano I, Katano Y, Goto H.
    Clin Infect Dis; 2005 Mar 15; 40(6):e49-54. PubMed ID: 15736006
    [Abstract] [Full Text] [Related]

  • 10. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M, Penning M, van Putten M, Lukashov V, van den Hoek A, McMorrow M, Goudsmit J.
    Hepatology; 1999 Apr 15; 29(4):1288-98. PubMed ID: 10094977
    [Abstract] [Full Text] [Related]

  • 11. Acute hepatitis C: prevention and treatment.
    Ozaras R, Tahan V.
    Expert Rev Anti Infect Ther; 2009 Apr 15; 7(3):351-61. PubMed ID: 19344247
    [Abstract] [Full Text] [Related]

  • 12. [Hepatitis C virus infection. Overview. SEVHEP (Swiss Experts on Viral Hepatitis)].
    Grob PJ, Negro F, Renner EL.
    Praxis (Bern 1994); 2000 Oct 05; 89(40):1587-604. PubMed ID: 11081358
    [Abstract] [Full Text] [Related]

  • 13. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.
    Baumert TF, Wellnitz S, Aono S, Satoi J, Herion D, Tilman Gerlach J, Pape GR, Lau JY, Hoofnagle JH, Blum HE, Liang TJ.
    Hepatology; 2000 Sep 05; 32(3):610-7. PubMed ID: 10960457
    [Abstract] [Full Text] [Related]

  • 14. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.
    Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, Chaplinskas S, Peters L, Karlsson A, Katlama C, Toro C, Kupfer B, Vogel M, Lundgren J, EuroSIDA Study Group.
    J Infect Dis; 2008 Nov 01; 198(9):1337-44. PubMed ID: 18767985
    [Abstract] [Full Text] [Related]

  • 15. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy.
    Januszkiewicz-Lewandowska D, Wysocki J, Pernak M, Nowicka K, Zawada M, Rembowska J, Lewandowski K, Mańkowski P, Nowak J.
    Jpn J Infect Dis; 2007 Feb 01; 60(1):29-32. PubMed ID: 17314422
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis C virus infection: an overview.
    Hwang SJ.
    J Microbiol Immunol Infect; 2001 Dec 01; 34(4):227-34. PubMed ID: 11825001
    [Abstract] [Full Text] [Related]

  • 17. High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives.
    Scott JD, McMahon BJ, Bruden D, Sullivan D, Homan C, Christensen C, Gretch DR.
    Clin Infect Dis; 2006 Apr 01; 42(7):945-52. PubMed ID: 16511757
    [Abstract] [Full Text] [Related]

  • 18. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
    Akuta N, Suzuki F, Sezaki H, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Watahiki S, Sato J, Kobayashi M, Arase Y, Ikeda K, Kumada H.
    J Med Virol; 2006 Jan 01; 78(1):83-90. PubMed ID: 16299715
    [Abstract] [Full Text] [Related]

  • 19. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML, Chuang WL, Dai CY, Lee LP, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Tsai SL, Kuo HT.
    Transl Res; 2006 Sep 01; 148(3):120-7. PubMed ID: 16938649
    [Abstract] [Full Text] [Related]

  • 20. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C.
    Radkowski M, Gallegos-Orozco JF, Jablonska J, Colby TV, Walewska-Zielecka B, Kubicka J, Wilkinson J, Adair D, Rakela J, Laskus T.
    Hepatology; 2005 Jan 01; 41(1):106-14. PubMed ID: 15619235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.